Document Type : Original Article
Authors
- . Vahid Hatami Garosi
- . Sepideh Tanhaie 1
- . Fakhreddin Chaboksavar 2
- . Teymour Kamari
- . Parvin Abdi Gheshlaghi
- . Razie Toghroli 3
- . Simin Soltaninezhad 4
- . Seyyed Amar Azizi 5
- . Vahid Yazdani
- . Fatemeh Mahmoodi 6
1 Department of Health Education and Promotion, School of Health, Iran University of Medical Sciences, Tehran, Iran
2 Nursing Care Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R. Iran
3 Social Determinants in Health Promotion Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
4 Department of Radiology, School of Medicine, Kerman University of Medical Science, Kerman, Iran
5 PhD. Student of Social Welfare and Health, University of Social Welfare and Rehabilitation Sciences,Tehran, Iran
6 Department of Health Education and Promotion, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Abstract
Coronavirus disease 2019 (COVID‑19), caused by severe acute respiratory syndrome coronavirus
2, was first reported in December 2019 in Wuhan, Hubei province, China. It is now known as a
pandemic and a global crisis due to rapid human‑to‑human transmission with the vast expansion
that has affected almost all countries. The primary source of the disease is still unknown, but it is
possible that the virus was transmitted through bat to an intermediate host and then to humans.
The main and early symptoms of COVID‑19 infection are fatigue, fever, dry cough, myalgia, and
dyspnea. The incubation period of the disease is about 2–14 days, which is one of the important
parameters for planning to prevent disease outbreak. PT‑polymerase chain reaction test is used to
diagnose the disease; chest computed tomography scan, chest X‑ray, blood tests, and symptoms
are also very helpful in diagnosing the disease. There is a strong emphasis on controlling infections
and hand hygiene to prevent the transmission of the disease. There is not enough knowledge about
this disease yet, and there are no specific vaccines or medications available to prevent and treat this
disease. The current review study uses articles indexed on databases of Embase, Elsevier, PubMed,
and World Health Organization and Centers for Disease Control and Prevention, and keywords of
coronavirus, COVID‑19, acute respiratory distress syndrome and China.
Keywords
Schwartz NG, et al. Epidemiology of Covid‑19 in a long‑term care
facility in king county, washington. N Engl J Med 2020;382:205‑11.
2. Rodriguez-MoralesAJ, Cardona‑Ospina JA, OcampoGE, Peña VR,
Rivera HY, Escalera‑Antezana JP, et al. Clinical, laboratory
and imaging features of COVID‑19: A systematic review and
meta‑analysis. Travel Med Infect Diseas 2020;34:101623.
3. Jalilian N, Ziapour A, Mokari Z, Kianipour N. A study of the
relationship between the components of spiritual health and
happiness of students at Kermanshah University of Medical
Sciences in 2016. Ann Trop Med Public Health 2017;10: 1010-4.
4. Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease
2019 (COVID‑19): Current status and future perspective. Int J
Antimicrob Agents 2020;55:105951.
5. Yoosefi LebniY, Abbas J, MoradiF, SalahshoorMR, ChaboksavarF,
Irandoost SF, et al. How the COVID‑19 pandemic effected
economic, social, political, and cultural factors: A lesson from
Iran. Int J Soc Psychiatry 2020: 1‑3. In Press. https://journals.
sagepub.com/doi/full/100.1177/0020764020939984
6. Yoosefi lebni, J., Irandoost, S., Mehedi, N., Sedighi, S., &
Ziapour, A. The Role of Celebrities during the COVID-19
Pandemic in Iran: Opportunity or Threat? Disaster Med
Public Health Preparedness., 2021; 1‑7. In Press.doi: 10.1017/
dmp.2020.498.
7. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic
characterization and epidemiology of 2019 novel coronavirus:
Implications for virus origins and receptor binding. Lancet
2020;395:565‑74.
8. Abbas J, Wang D, Su Z, Ziapour A. The Role of Social Media in
the Advent of COVID-19 Pandemic: Crisis Management, Mental
Health Challenges and Implications. Risk Manag Healthcare
Policy 2021;14:1917-32.
9. NeJhaddadgar N, Ziapour A, Zakkipour G, Abbas J, Abolfathi M,
Shabani M. Effectiveness of telephone‑based screening and
triage during COVID‑19 outbreak in the promoted primary
healthcare system: a case study in Ardabil province, Iran. J Public
Health 2020:1‑6. In Press. https://link.springer.com/article
/10.1007/s10389‑020‑01407‑8
10. Ziapour A, Zokaei A, Kahrizy F. A Theoretical study of the
standing of social investment in the health sector. Soc Sci
2016;11:3682‑7.
11. Abbasi P, Kianipour N, Ziapour A. A study of the status of
students’ social health at kermanshah university of medical
sciences and the role of demographic variables. J Clin Diagn Res
2018;12:VC10‑4.
12. Farnoosh G, Alishiri G, Hosseini Zijoud SR, Dorostkar R,
Farahani JA. Understanding the severe acute respiratory
syndrome coronavirus 2 (SARS‑CoV‑2) and coronavirus
disease (COVID‑19) Based on available evidence‑a narrative
review. J Mil Med 2020;22:1‑11.
13. Mohammadi M, Esfandnia A, Rezaei S, Ziapour A. Performance
evaluation of hospitals under supervision of kermanshah
medical sciences using pabonlasoty diagram of a five‑year
period (2008‑2012). Life Sci J 2014;11 (1).):77‑81.
14. Montazeri N, Kianipour N, Nazari B, Ziapour A, Bakhshi S. Health
promoting behaviors among university students: a case-sectional
study of Kermanshah University of Medical Sciences. Int J Pediatr
2017;5:5091-9.
15. Abbasi P, Kianipour N, Demir Özdenk G, Ziapour A. Dataset
of leisure time among students at Kermanshah University of
Medical Sciences and its relationship with health‑related quality
of life (HRQOL). Data Brief 2018;21:122‑7.
16. Azizi MR, Atlasi R, Ziapour A, Abbas J, Naemi R. Innovative human resource management strategies during the COVID-19
pandemic: A systematic narrative review approach. Heliyon
2021:In Press. e07233.
17. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, et al.
Clinical progression and viral load in a community outbreak of
coronavirus‑associated SARS pneumonia: A prospective study.
Lancet 2003;361:1767‑72.
18. Abbas J, Ling J, Ziapour A, Hamza Shuja K. The Role of
interventions to manage reduce covid‑19 mortality rate of the
COVID‑19 patients worldwide. Foundation Univ J Psychol
2020;4:33‑6.
19. Bhattacharya S, Singh A, Hossain MM. Health system
strengthening through Massive Open Online Courses (MOOCs)
during the COVID‑19 pandemic: An analysis from the available
evidence. J Educ Health Promot 2020;9:195.
20. Lechien JR, Chiesa‑Estomba CM, De Siati DR, Horoi M, Le Bon SD,
Rodriguez A, et al. Olfactory and gustatory dysfunctions as a
clinical presentation of mild‑to‑moderate forms of the coronavirus
disease (COVID‑19): A multicenter european study. Europ Arch
Oto‑Rhino‑Laryngol 2020;277:2251‑61.
21. Abbasi P, Kianipour N, Ziapour A. Correlation of the components
of student’s lifestyles and their health promotion. J Clin Diagn
Res 2018;12:LC01‑4.
22. Karyani KA, Faramani SR, Amini S, Doroh RV, Berenjian F,
Dizaj M, et al. World one‑hundred days after COVID‑19 outbreak:
Incidence, case fatality rate, and trend. J Educ Health Promot
2020;9:199.
23. Kootesh BR, Raisi M, Ziapour A. Investigation of relationship
internet addict with mental health and quality sleep in students.
Acta Med Mediterran 2016;32(5):1921-5.
24. Lai CC, Liu YH, Wang CY, Wang YH, Hsueh SC, Yen MY,
et al. Asymptomatic carrier state, acute respiratory disease, and
pneumonia due to severe acute respiratory syndrome coronavirus
2 (SARSCoV‑2): Facts and myths. J Microbiol Immunol Infect
2020;53:404‑12.
25. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute
respiratory syndrome coronavirus 2 (SARS‑CoV‑2) and corona
virus disease‑2019 (COVID‑19): The epidemic and the challenges.
Int J Antimicrobial Agents 2020;55:105924.
26. Panahi S, Ashrafi‑rizi H, Panahi M. Exposure to
coronavirus (COVID‑19) using narrative and simulated
experience approaches: A commentary. J Educ Health Promot
2020;9:135.
27. Yoosefi Lebni J, Ziapour A, Mehedi N, Irandoost SF. The Role of
Clerics in Confronting the COVID-19 Crisis in Iran. J Relig Health.
2021: In Press. 1-8.
28. Santacroce L, Charitos IA, Del Prete R. COVID‑19 in Italy: An
overview from the first case to date. Electronic J General Med
2020;17:Em235.
29. Shanbehzadeh M, Kazemi‑Arpanahi H, Mazhab‑Jafari K,
Haghiri H. Coronavirus disease 2019 (COVID‑19) surveillance
system: Development of COVID‑19 minimum data set and
interoperable reporting framework. J Educ Health Promot
2020;9:203.
30. Lu Cw, Liu Xf, Jia Zf. 2019-nCoV transmission through the
ocular surface must not be ignored. Lancet (London, England)
2020;395:e39.
31. Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus
in tears and conjunctival secretions of patients with SARS‐CoV‐2
infection. J Med Virol 2020;92:589‑94.
32. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical
characteristics of 138 hospitalized patients with 2019 novel
coronavirus‑infected pneumonia in Wuhan, China. JAMA
2020;323:1061‑9.
33. Kalhori RP, Ziapour A, Kianipour N, Foroughinia A. A study of
the relationship between lifestyle and happiness of students at
Kermanshah University of Medical Sciences over 2015–2016. Ann
Trop Med Public Health 2017;10:1004.
34. Zokaei A, Ziapour A, Kianipour N. Evaluation of relationship
between organizational culture and job satisfaction among
employee of Kermanshah University of Medical Sciences. Soc
Sci 2016;11: 4005-12.
35. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical
characteristics of 2019 novel coronavirus infection in China.
MedRxiv 2020;26: 1‑6.
36. Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019
novel coronavirus (2019‑nCoV) infections among travellers from
Wuhan, China, 20‑28 January 2020. Euro Surveill 2020;25 (5):1‑5.
37. James SL, Lucchesi LR, Bisignano C, Castle CD, Dingels ZV,
Fox JT, et al. Morbidity and mortality from road injuries: results
from the Global Burden of Disease Study 2017. Injury prev
2020;26(Supp 1):46-56.
38. Quilty BJ, Clifford S, Flasche S, Eggo RM; CMMID nCoV working
group. Effectiveness of airport screening at detecting travellers
infected with novel coronavirus (2019‑nCoV). Euro Surveill
2020;25 (5):1‑5.
39. Nazari B, Bakhshi S, Kaboudi M, Dehghan F, Ziapour A,
Montazeri N. A Comparison of quality of life, anxiety and
depression in children with cancer and healthy children,
kermanshah‑iran. Int J Pediatr 2017;5:5305‑14.
40. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al.
The incubation period of coronavirus disease 2019 (COVID‑19)
from publicly reported confirmed cases: Estimation and
application. Ann Intern Med 2020;172:577‑82.
41. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H,
et al. First case of 2019 novel coronavirus in the United States.
N Engl J Med 2020;382:929‑36.
42. World Health Organization. Clinical Management of Severe Acute
Respiratory Infection When Novel Coronavirus (nCoV)Infection
is Suspected: Interim Guidance, 25 January 2020. World Health
Organization; 2020.
43. Rezabakhsh A, AlaA, KhodaeiSH. Novel coronavirus (COVID‑19):
A new emerging pandemic threat. J Res Clin Med 2020;8:1‑6.
44. Djalante R, Lassa J, Setiamarga D, Mahfud C, Sudjatma A,
Indrawan M, et al. Review and analysis of current responses to
COVID‑19 in Indonesia: Period of January to March 2020. Progress
Disaster Sci 2020;6:100091.
45. Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E,
et al. Surviving Sepsis Campaign: Guidelines on the management
of critically ill adults with Coronavirus Disease 2019 (COVID‑19).
Intensive Care Med 2020;46:854‑87.
46. YeZ, ZhangY, WangY, HuangZ, Song B. Chest CT manifestations
of new coronavirus disease 2019 (COVID‑19): A pictorial review.
Eur Radiol 2020;30:4381‑9.
47. Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity
of Chest CT for COVID‑19: Comparison to RT‑PCR. Radiology
2020;296:E115‑E117.
48. Phua J, Weng L, Ling L, Egi M, Lim CM, Divatia JV, et al. Intensive
care management of coronavirus disease 2019 (COVID‑19):
Challenges and recommendations. Lancet Respir Med
2020;8:506‑17.
49. Abbasi P, Timareh M, Ziapour A, Kianipour N. A study of the
components of happiness and the role of demographic variables
among the students at kermanshah university of medical sciences.
J Postgrad Med Instit 2018;32:173‑8.
50. Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological
findings from 81 patients with COVID‑19 pneumonia in Wuhan,
China: A descriptive study. Lancet Infect Dis 2020;20:425‑34.
51. Hsih WH, Cheng MY, Ho MW, Chou CH, Lin PC, Chi CY, et al.
Featuring COVID‑19 cases via screening symptomatic patients
with epidemiologic link during flu season in a medical center of
central Taiwan. J Microbiol Immunol Infect 2020;53:459‑66.
52. Yeh KM, Chiueh TS, Siu LK, Lin JC, Chan PK, Peng MY, et al.
Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan
hospital. J Antimicrob Chemother 2005;56:919‑22.
53. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir
and chloroquine effectively inhibit the recently emerged novel
coronavirus (2019‑nCoV) in vitro. Cell Res 2020;30:269‑71.
54. Cunningham AC, Goh HP, Koh D. Treatment of COVID‑19: Old
tricks for new challenges. Crit Care 2020;24:91.
55. Kaboudi M, Dehghan F, Ziapour A. The effect of acceptance and
commitment therapy on the mental health of women patients with
type II diabetes. Ann Trop Med Public Health 2017;10:1709‑13.
56. Mehta N, Mazer‑Amirshahi M, Alkindi N, Pourmand A.
Pharmacotherapy in COVID‑19; A narrative review for emergency
providers. Am J Emerg Med 2020;38:1488‑93.
57. Kaboudi M, Kianipour N, Ziapour A, Dehghan F. A study
of health literacy components and their relationships with
health‑promoting behaviors in students at kermanshah university
of medical sciences. Int J Pediatr 2017;5:6721‑29.
58. Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity
of chest CT for COVID‑19: Comparison to RT‑PCR. Radiology
2020;296:E115‑7.
)